| Oct 3 |
Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down
|
| Oct 3 |
High Growth Tech Stocks To Watch In October 2024
|
| Oct 3 |
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
|
| Sep 30 |
Brookfield asks for more time to weigh potential Grifols deal - report
|
| Sep 30 |
Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say
|
| Sep 25 |
Sector Update: Health Care Stocks Fall Late Afternoon
|
| Sep 19 |
Grifols Investor Group With 7.7% Holding Seeks Seat on Board
|
| Sep 13 |
Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System
|
| Sep 10 |
Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’
|
| Sep 5 |
Grifols Class B stock falls as Brookfield reportedly seeks lower price
|
